Mesa Laboratories, Inc.
MLAB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 11.5% | -1.3% | 18.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.6% | 61.6% | 61% | 59.2% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 17.6% | -110.3% | 17.1% | 17.6% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -0.8% | -117.6% | 0.4% | 1% |
| EPS Diluted | -0.36 | -47.2 | 0.17 | 0.35 |
| % Growth | 99.2% | -27,864.7% | -51.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |